tbuckley/cabot-search huggingface dataset:
Impact of the 1985 CDC Lead Statement— Savannah, Georgia
Journal: JAMA (1987)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Clinical Management of the Constipated Patient
Authors: John H. Pemberton
Journal: Annals of Internal Medicine (1995)

Letters15 April 1995Clinical Management of the Constipated PatientJohn H. Pemberton, Michael Camilleri, and James W. FleshmanJohn H. PembertonMedical Associates Clinic, Dubuque, IA 52001. Mayo Foundation, Rochester, MN 55905. Jewish Hospital, St. Louis, MO 63110.Search for more papers by this author, Michael CamilleriMedical Associates Clinic, Dubuque, IA 52001. Mayo Foundation, Rochester, MN 55905. Jewish Hospital, St. Louis, MO 63110.Search for more papers by this author, and James W. FleshmanMedical Associates Clinic, Dubuque, IA 52001. Mayo Foundation, Rochester, MN 55905. Jewish Hospital, St. Louis, MO 63110.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-122-8-199504150-00022 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE:We share the opinion expressed by Dr. Runde that abdominal colectomy and ileorectostomy must be done with caution. No responsible surgeon or gastroenterologist would lightly suggest that a patient have an ileorectostomy for slow-transit constipation unless the disease had left the patient with a severely limited lifestyle. Before any surgery is considered, each patient must overcome several hurdles. Patients must have quantifiably significant slow transit (proven by clinical markers or scintigraphy) and must show normal pelvic floor function. In older patients, a history of fecal incontinence must also be ruled out. We agree that ileorectostomy in the setting ...REFERENCE1. Pemberton JH, Rath DM, Ilstrup DM. Evaluation and surgical treatment of severe chronic constipation. Ann Surg. 1991; 214:403-13. Google Scholar Author, Article, and Disclosure InformationAffiliations: Medical Associates Clinic, Dubuque, IA 52001. Mayo Foundation, Rochester, MN 55905. Jewish Hospital, St. Louis, MO 63110. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 15 April 1995Volume 122, Issue 8Page: 632KeywordsColectomyConstipationForecastingGastroenterology and hepatologyIncontinenceInflammatory bowel diseaseIrritable bowel syndromeRadionuclide imagingSurgeonsSurgery Issue Published: 15 April 1995 CopyrightCopyright © 1995 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...
Current Comment
Journal: JAMA (2011)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Incidence of cancer of the cervix: triumph or tragedy?
Authors: F. Matthews
Journal: JAMA (1989)

<h3>To the Editor.—</h3> Few people besides Dr Koss<sup>1</sup>could have covered the strong and weak points of the Papanicolaou (Pap) smear so well. However, I raise an objection to the subtitle of his article, "A Triumph and a Tragedy." For those of us from the pre-Pap years, the triumph should be trumpeted abroad; the tragedy deserves no more than extremely fine print. There is considerable danger in even suggesting that the two are equal. To me, a pathology resident at a large university hospital in the late 1950s, it seemed that we did an autopsy a week on some woman between 30 and 50 years of age who had died of invasive cervical carcinoma. Carcinoma in situ was a rarity, found almost exclusively adjacent to invasive tumors; I did not hear of cervical dysplasia until after my training. Today, solely because of 30 years of using the Pap smear,
Myelodysplastic Syndromes
Authors: _ _
Journal: Journal of the National Comprehensive Cancer Network (2008)

Myelodysplastic syndromes (MDS) represent myeloid clonal hemopathies with relatively heterogeneous spectrums of presentation. The major clinical problems in these disorders are morbidities caused by patients' cytopenias and the potential for MDS to evolve into acute myeloid leukemia (AML). Managing MDS is complicated by the generally advanced age of patients, attendant non-hematologic comorbidities, and older patients' relative inability to tolerate some therapies. In addition, when the illness progresses into AML, these patients experience lower response rates to standard therapy than patients with de novo AML. Important changes from the 2008 version of the guidelines include the addition of lenalidomide as a possible treatment for symptomatically anemic non-del(5q) patients whose anemia does not respond to initial therapy. For the most recent version of the guidelines, please visit NCCN.org
Screening for Suicide Risk in Adults: A Summary of the Evidence for the U.S. Preventive Services Task Force
Authors: Bradley N. Gaynes, Suzanne L. West, Carol A. Ford, Paul Frame, Jonathan Klein, Kathleen N. Lohr
Journal: Annals of Internal Medicine (2004)

Background: Suicide is the 11th leading cause of death and the seventh leading cause of years of potential life lost in the United States. Although suicide is of great public health significance, its clinical management is complicated. Purpose: The authors systematically reviewed the literature to determine whether screening for suicide risk in primary care settings decreases morbidity, mortality, or both. Data Sources: MEDLINE (1966 to 17 October 2002), PsycINFO, Cochrane databases, hand-searched bibliographies, and experts. Study Selection: For screening, only English-language studies performed in primary care settings were examined. For treatment, randomized, controlled trials and cohort studies were included if they were performed in any setting where suicide completions, suicide attempts, or suicidal ideation were reported. Data Extraction: A primary reviewer abstracted data on key variables of study sample, design, and outcomes; a second reviewer checked information accuracy against the original articles. Data Synthesis: No study directly addressed whether screening for suicide in primary care reduces morbidity and mortality. The remainder of the review focused on the questions of reliable screening tests for suicide risk and the effectiveness of interventions to decrease depression, suicidal ideation, and suicide attempts or completion. One screening study provided limited evidence for the accuracy of suicide screening in a primary care setting. Intervention studies provided fair and mixed evidence that treating those at risk for suicide reduces the number of suicide attempts or completions. The evidence suggests mild to moderate improvement for interventions addressing intermediate outcomes such as suicidal ideation, decreased depressive severity, decreased hopelessness, or improved level of function. Conclusion: Because of the complexity of studying the risk for suicide and the paucity of well-designed research studies, only limited evidence guides the primary care clinician's assessment and management of suicide risk.
Evaluation of Small Bowel Barium Motor Meal, with Emphasis on Effect of Volume of Barium Suspension Ingested
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Streptococcal pharyngitis in rural practice. Rational medical management
Authors: H. Jackson
Journal: JAMA (1966)

The current medical concepts regarding group A β-hemolytic streptococcal pharyngitis are well documented. This study demonstrates that these concepts can form the basis of rational medical management in rural general practice; that this management is practical in regard to time and money expended; and that private patients willingly cooperate. Of 1,052 patients with proved streptococcal pharyngitis, 1,045 (99%) received ten full days of antibiotic therapy, and 808 (76.6%) returned for follow-up cultures. Of 633 families involved, 503 (79.2%) families had every household contact cultured, and 567 (89.5%) of the families had at least 75% of household contacts cultured. Since adoption of this management, the incidence of rheumatic fever has apparently decreased sharply in the county.
Death Rates of People Who Carry the Gene for Ataxia-Telangiectasia
Journal: Annals of Internal Medicine (2000)

Summaries for Patients21 November 2000Death Rates of People Who Carry the Gene for Ataxia-TelangiectasiaSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-133-10-200011210-00004 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail What is the problem and what is known about it so far?Ataxia-telangiectasia is an inherited disease. People with this disease begin having problems with balance and walking during early childhood. Later, they develop skin abnormalities, frequent respiratory infections, and high rates of cancer (especially leukemia and lymphoma). To have the disease, a person needs to inherit two copies of the abnormal gene, one from each parent. Relatives of patients with ataxia-telangiectasia can be “carriers” of the abnormal gene. Carriers have only one copy of the abnormal gene. Previous studies have shown that carriers of the ataxia-telangiectasia gene have a ... Author, Article, and Disclosure InformationAffiliations: The summary below is from the full report titled “Mortality Rates among Carriers of Ataxia-Telangiectasia Mutant Alleles.” It is in the 21 November 2000 issue of Annals of Internal Medicine (volume 133, pages 770-778). The authors are Y Su and M Swift.Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoMortality Rates among Carriers of Ataxia-Telangiectasia Mutant Alleles Yun Su and Michael Swift Metrics 21 November 2000Volume 133, Issue 10Page: I-51KeywordsBloodCardiovascular therapyDeath ratesGenetic determinismHeart diseasesLongitudinal studiesLymphocytic leukemiaLymphomaUpper respiratory tract infectionsWalking ePublished: 21 November 2000 Issue Published: 21 November 2000 Copyright & PermissionsCopyright © 2000 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Global Epidemiology: A Geography of Disease and Sanitation. Volume II: Africa and the Adjacent Islands
Journal: JAMA (1952)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Early Restoration Program for Patient Following Stroke Called Necessary
Journal: JAMA (1964)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Total Hip and Total Knee Replacement
Authors: William H. Harris, Clement B. Sledge
Journal: New England Journal of Medicine (1990)

Replacement of the arthritic knee now has clinical results that equal or exceed those of hip replacement in terms of pain relief, satisfactory function, and survival of the implant after 10 years.77 , 78 These results have not been achieved by any one person or center, but by the combined efforts of engineers and surgeons from many countries. There has been a slow evolution of concepts, techniques, and designs over the past 30 years, with enormous strides in the past 15 years. At the present time, approximately 120,000 total knee replacements are performed yearly in the United States, and the total hospital . . .
Chemotherapy in the treatment of leukemia and Wilms' tumor
Authors: S. Farber
Journal: JAMA (1966)

Twenty years ago, one fourth of patients with the many diseases grouped under the word "cancer" were cured because of the greatly improved skills of surgeons and radiotherapists, aided by many specialties which contributed to the care of the patient. Improved techniques for the early diagnosis of many forms of cancer, combined with public education, decreased the serious lag which too often occurred between onset of symptoms of the tumor and treatment. For the 75% with cancer incurable by methods of treatment then available, new therapeutic weapons, or methods of prevention were required. It seemed unlikely that even the constantly improving skills of surgeons alone would increase the cure rate to an important degree. The full potential of radiotherapy was not then fully developed, nor is it even today. Prevention of cancer is the ideal for which we must strive. It is possible that this could be accomplished by the
Reliability of PEF diaries
Authors: W ANEES, V HUGGINS, P S BURGE
Journal: Thorax (2001)

COPD exacerbationsWe read with interest the paper by Cotton and associates 1 on early discharge for patients with exacerbations of chronic obstructive pulmonary disease and the accompanying editorial by Killen and Ellis. 2 In both publications the 1991 study of our RespiCare home care programme was referenced, 3 and both asserted that our programme was not cost eVective.In fact, our study reached the opposite conclusion-namely, that the Respi-Care programme was shown to be cost eVective.Actual direct care charges in US dollars were used in our calculations of both pre-programme and on-programme costs.Additionally, administrative costs of operating RespiCare were added into the onprogramme costs.Our findings showed that, while hospitalisation costs substantially decreased during the programme, home care costs increased.However, the decrease in hospital costs more than oVset the subsequent increase in home care costs, with a total cost savings of $328 US dollars per patient per month or $3956 per year being realised for those on the RespiCare programme.Although the emphasis of the work was on improvements in clinical outcome, the cost savings were a significant and important aspect of our study.I hope this clarifies any misunderstanding created by the recent articles.
THE BEHAVIOR OF PHOSPHATES IN THE BODY
Journal: JAMA (1921)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Britannica
Authors: Malcolm Sickels
Journal: JAMA (1998)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Author Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis
Authors: Luigina Romani, Vasilis Oikonomou, Silvia Moretti, Rossana G Iannitti, Maria Cristina D’Adamo, Valeria R Villella, Marilena Pariano, Luigi Sforna, Monica Borghi, Marina M Bellet, Francesca Fallarino, Maria Teresa Pallotta, Giuseppe Servillo, Eleonora Ferrari, Paolo Puccetti, Guido Kroemer, Mauro Pessia, Luigi Maiuri, Allan L Goldstein, Enrico Garaci
Journal: Nature Medicine (2018)